IL99715A - Pharmaceutical preparations containing a history of indulgence are used - Google Patents

Pharmaceutical preparations containing a history of indulgence are used

Info

Publication number
IL99715A
IL99715A IL9971591A IL9971591A IL99715A IL 99715 A IL99715 A IL 99715A IL 9971591 A IL9971591 A IL 9971591A IL 9971591 A IL9971591 A IL 9971591A IL 99715 A IL99715 A IL 99715A
Authority
IL
Israel
Prior art keywords
headache
compound
treatment
withdrawal
use according
Prior art date
Application number
IL9971591A
Other languages
English (en)
Hebrew (he)
Other versions
IL99715A0 (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL99715A0 publication Critical patent/IL99715A0/xx
Publication of IL99715A publication Critical patent/IL99715A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
IL9971591A 1990-10-12 1991-10-11 Pharmaceutical preparations containing a history of indulgence are used IL99715A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909022250A GB9022250D0 (en) 1990-10-12 1990-10-12 Medicaments

Publications (2)

Publication Number Publication Date
IL99715A0 IL99715A0 (en) 1992-08-18
IL99715A true IL99715A (en) 1996-01-19

Family

ID=10683660

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9971591A IL99715A (en) 1990-10-12 1991-10-11 Pharmaceutical preparations containing a history of indulgence are used

Country Status (16)

Country Link
US (1) US5376672A (fr)
EP (1) EP0552205B1 (fr)
JP (1) JP3159263B2 (fr)
KR (1) KR0178762B1 (fr)
AT (1) ATE168006T1 (fr)
AU (1) AU660153B2 (fr)
CA (1) CA2093527A1 (fr)
DE (1) DE69129750T2 (fr)
DK (1) DK0552205T3 (fr)
ES (1) ES2118090T3 (fr)
GB (1) GB9022250D0 (fr)
IE (1) IE913580A1 (fr)
IL (1) IL99715A (fr)
TW (1) TW212756B (fr)
WO (1) WO1992006688A1 (fr)
ZA (1) ZA918117B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122008000042I1 (de) * 1993-12-28 2009-01-02 Merz Pharma Gmbh & Co Kgaa Verwendung der neurotoxischen Komponente des Botulinum Toxins zur Behandlung von Muskelspasmen
ES2421306T3 (es) * 1994-12-12 2013-08-30 Omeros Corporation Solución de irrigación y procedimiento para inhibir el dolor, la inflamación y los espasmos
US20040068000A1 (en) * 2002-10-02 2004-04-08 Mintong Guo Compression coated tablets
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
WO2005123043A2 (fr) * 2004-06-10 2005-12-29 Duramed Pharmaceuticals, Inc. Formulations de sumatriptan absorbables au travers des membranes biologiques, et methodes de production et d'utilisation desdites formulations
US8653066B2 (en) 2006-10-09 2014-02-18 Charleston Laboratories, Inc. Pharmaceutical compositions
US8124126B2 (en) 2008-01-09 2012-02-28 Charleston Laboratories, Inc. Pharmaceutical compositions
US20100287502A1 (en) * 2009-05-11 2010-11-11 Olympus Imaging Corp. Image search device and image search method
US8304179B2 (en) * 2009-05-11 2012-11-06 Taiwan Semiconductor Manufacturing Company, Ltd. Method for manufacturing a semiconductor device using a modified photosensitive layer
EP3311667A1 (fr) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Compositions pharmaceutiques
WO2017152130A1 (fr) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Compositions pharmaceutiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
GR79215B (fr) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative

Also Published As

Publication number Publication date
EP0552205A1 (fr) 1993-07-28
AU660153B2 (en) 1995-06-15
ATE168006T1 (de) 1998-07-15
KR0178762B1 (ko) 1999-03-20
US5376672A (en) 1994-12-27
JPH06501935A (ja) 1994-03-03
ES2118090T3 (es) 1998-09-16
CA2093527A1 (fr) 1992-04-13
JP3159263B2 (ja) 2001-04-23
WO1992006688A1 (fr) 1992-04-30
ZA918117B (en) 1992-08-26
GB9022250D0 (en) 1990-11-28
IE913580A1 (en) 1992-04-22
DK0552205T3 (da) 1999-04-19
EP0552205B1 (fr) 1998-07-08
IL99715A0 (en) 1992-08-18
DE69129750T2 (de) 1998-11-12
TW212756B (fr) 1993-09-11
DE69129750D1 (de) 1998-08-13
AU8642291A (en) 1992-05-20

Similar Documents

Publication Publication Date Title
JP4925074B2 (ja) ミルタザピンと1種以上の選択的セロトニン再取り込み阻害剤とを含む医薬組成物
US4507323A (en) Treatment of psychosexual dysfunctions
AU737086B2 (en) Butyrate derivatives in the treatment of fibromyalgia and chronic fatigue syndrome
US8673979B2 (en) Pharmaceutical compositions for headache, migraine, nausea and emesis
EP0226266B1 (fr) Utilisation d'un dérivé du tétrahydrocarbazolone pour la fabrication de médicaments
CA2053190C (fr) Preparation de medicaments pour le traitement de l'asthme a l'aide de la (s)-o-fluoromethylhistidine et de ses esters
JP3984787B2 (ja) 機能性及び/又は器質性痛み症候群の治療のための製薬組成物の調製のためのアセチルコリンエステラーゼ阻害剤の使用
US5506270A (en) Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women
EP0552205B1 (fr) Nouvelle utilisation medicale pour un certain derive d'indole et composition pharmaceutique le contenant
US20130079304A1 (en) Pharmaceutical Compositions for the Treatment of Fungal Infections
US5693654A (en) Medicaments for treating intraocular pressure
AU619420B2 (en) Treatment of depression
IE851848L (en) Propiophenone compound against sexual dysfunction
US20090306204A1 (en) Pharmaceutical Composition Comprising Cyclobenzaprine and Aceclofenac in Association
ES2214305T3 (es) Utilizacion de la ciamemazina en el tratamiento de la eliminacion brusca de las benzodiazepinas.
AU658169B2 (en) Pharmaceutical composition containing granisetron and dexamethasone
JP2004513916A (ja) 複合的な5−ht1aアゴニストおよび選択的セロトニン再取り込み阻害剤の新規な使用
RU2275905C2 (ru) Фармацевтические композиции от головной боли, мигрени, тошноты и рвоты
Cazzola Pharmacological Treatment Strategies in Stable Chronic Obstructive Pulmonary Disease
WO2005077371A1 (fr) Utilisation de la levocetirizine pour la preparation d'un medicament
MXPA97004579A (en) Pharmaceutical composition comprising mirtazapine and one or more selective seroton reabsorption inhibitors

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees